As core effector cells in antitumor immunity, CD8+ T cells enhance tumor cell lysis by secreting interferon-γ (IFN-γ), which inhibits the expression of SLC7A11 and SLC3A2—subunits of the system Xc– in tumor cells. Here, CD8A is linked to neoplasm.